Position in ASND
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$413,052,191
+$11,028,800 QoQ
Shares Held
1,548,636
-11.9% QoQ
Ownership
2.36%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#12
of 308 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 99%
None 1%
Common Shares in ASND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLINGTON MANAGEMENT GROUP LLP holds $14,994,233,945 across 206 Biotechnology names. ASND ranks #11 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,247,658 | $1,613,209,155 | |
| 2 | ARGX |
Argenx SE
|
930,548 | $863,334,513 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,270,087 | $791,950,042 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,843,415 | $719,794,757 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,110,407 | $635,295,816 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
7,651,415 | $606,680,693 | |
| 7 | CYTK |
Cytokinetics Inc
|
6,931,770 | $590,517,483 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
825,714 | $443,367,129 |
All Filings in ASND
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $413,052,191 | 1,548,636 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $402,023,391 | 1,757,633 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $375,882,622 | 1,762,721 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $357,645,467 | 1,798,931 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $158,463,194 | 918,095 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $91,608,737 | 587,763 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $96,943,769 | 704,175 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $188,351,575 | 1,261,480 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $356,341,298 | 2,612,856 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $415,093,466 | 2,745,872 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $409,122,501 | 3,248,293 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $306,874,383 | 3,277,172 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $281,039,322 | 3,148,900 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $314,561,174 | 2,933,792 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $372,936,775 | 3,053,605 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $379,194,051 | 3,672,226 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $329,927,772 | 3,549,137 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $547,552,347 | 4,665,579 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $547,634,497 | 4,070,724 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $628,832,437 | 3,945,244 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $451,778,609 | 3,434,273 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $450,091,874 | 3,492,333 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $567,311,840 | 3,401,558 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $501,811,752 | 3,251,761 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $264,192,437 | 1,786,291 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $188,075,138 | 1,670,146 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||